[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Yoo Byung-don] Two executives of the bio company Sillajen, including former CEO Lee Yong-han, who are suspected of selling stocks after knowing undisclosed information in advance, have been arrested.


On the 17th, Judge Sung Bo-gi, in charge of warrants at the Seoul Southern District Court, issued arrest warrants requested by the prosecution for former Sillajen CEO Lee Yong-han (54) and former auditor Kwak Byung-hak (56), citing "risk of evidence destruction and flight."


They are suspected of using internal company information to sell a large amount of stocks before the public announcement of the clinical trial suspension of Sillajen's immuno-oncology drug 'Pexavac,' thereby avoiding significant losses.


Sillajen's stock price once soared due to expectations for Pexavac's development, but it plummeted after the clinical trial was halted.



Lee served as CEO from 2008 to 2009, and Kwak, a relative of current Sillajen CEO Moon Eun-sang (55), served as the company's auditor and inside director from 2012 to 2016.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing